Loading organizations...
Arklow is a maritime logistics and ship-owning company based in Arklow, Ireland, with a major operational hub in Rotterdam, that transports dry bulk commodities across European and international waters. The organization generates revenue by chartering vessels and providing freight transport services for agricultural, mining, and manufacturing businesses moving goods such as grain, cement, fertilizers, and steel. The enterprise operates a modern fleet of over 50 single-deck, box-hold cargo vessels ranging in capacity from 4,000 to 35,000 deadweight tonnage. To modernize its maritime operations, Arklow recently commissioned a series of 14,000-ton vessels from shipbuilding partner Ferus Smit and took delivery of several eco-friendly 6,800-ton ships, including the Arklow Racer and Arklow Resolve, built by Royal Bodewes. Arklow was founded in 1966 by Captain James Tyrrell, Felix O'Neill, and a consortium of local shipowners.
Arklow has raised $50K across 1 funding round.
Arklow has raised $50K in total across 1 funding round.
Arklow has raised $50K in total across 1 funding round.
Arklow's investors include Cometa, Hustle Fund, Magma Partners, MYASIAVC PTE LTD, Parade Ventures, Claire Diaz-Ortiz.
Arklow has raised $50K across 1 funding round. Most recently, it raised $50K Seed in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2022 | $50K Seed | — | Cometa, Hustle Fund, Magma Partners, MYASIAVC PTE LTD, Parade Ventures, Claire Diaz Ortiz | Announced |
No technology company named Arklow exists based on available information. Arklow primarily refers to a coastal town in County Wicklow, Ireland, known for industrial facilities rather than a standalone tech firm.[1][3] The most prominent "Arklow" entity in a tech-adjacent context is the former SAFC Arklow facility (now Merck Life Science), a 64,000 m² cGMP manufacturing site for commercial and late-stage active pharmaceutical ingredients (APIs) and advanced intermediates, specializing in contract manufacturing with capabilities like alkylation, esterification, and large-scale simulated moving bed chromatography.[3] This site, a subsidiary operation of Merck KGaA (via Sigma-Aldrich/MilliporeSigma), served pharmaceutical clients by producing high-purity excipients, solvents, and custom APIs under ICH Q7 and FDA standards, but Merck announced its closure by end-2028, impacting up to 100 jobs after a strategic portfolio review.[1][3]
A separate, emerging entity called Arklow appears in startup directories as a Lithuania-based company focused on compliance tools for AI models and datasets, though details on products, customers, or traction are limited.[5] Other mentions include Arklow Shipping (a 1966-founded maritime firm with 59 vessels using VSAT satellite tech for operations)[2] and generic software services in Arklow town,[4] but none match a prominent technology company profile.
The Merck Arklow facility evolved from SAFC (Sigma-Aldrich Fine Chemicals), established as a key hub for API production in Ireland, with expertise in process development, validation, and technology transfer for pharma clients.[3] It featured specialized equipment like 500L stainless steel filter dryers and vacuum tray ovens, supporting core chemistries and analytical services inspected by FDA and HPRA.[3] Operations faced recent headwinds, with Merck's 2028 closure decision following market dynamics and customer needs reviews, despite prior €440m investments in Irish sites like Carrigtwohill.[1]
The AI compliance startup "Arklow" lacks detailed founding info but is listed in Lithuanian startup maps, implying recent emergence in the AI governance space.[5] Arklow town itself has hosted diverse projects, from a €139m wastewater plant (operational 2024, aiding sustainable infrastructure)[6] to planned data centers leveraging proximity to Dublin.[7]
For the Merck Arklow facility (pharma manufacturing, not pure tech):
For the AI Arklow startup:
Arklow Shipping differentiates via fleet-scale adoption of Aura VSAT and Intellian systems for reliable maritime comms, but it's logistics-focused.[2]
Arklow entities intersect tech peripherally: the Merck facility rode biopharma manufacturing trends, enabling advanced therapies like vaccines and gene modalities via precise API production, though closure reflects consolidating market dynamics favoring larger sites like Carrigtwohill.[1][3] The AI Arklow taps AI regulation waves (e.g., EU AI Act), where compliance tools are critical amid rising scrutiny of models/datasets—timing aligns with 2024-2025 enforcement ramps.[5] Infrastructure in Arklow town supports tech growth, with data center plans harnessing Ireland's connectivity and the wastewater plant as a sustainability model unlocking development.[6][7] Overall, Arklow influences via industrial enablers rather than core innovation, amid Ireland's pharma/tech hub status.
Merck's Arklow winds down by 2028, shifting focus to expanded Irish sites—expect job transitions and portfolio migration, underscoring CDMO consolidation.[1] The AI Arklow could scale if AI regs tighten, riding trends like automated auditing and dataset provenance. Data centers may boost Arklow as an edge computing node near Dublin.[7] Watch for redevelopments post-closure, potentially pivoting pharma tech to data/AI infrastructure, tying back to Arklow's evolution from industrial base to potential tech adjunct.
